Journal of Leukocyte Biology,
Год журнала:
2023,
Номер
115(1), С. 85 - 99
Опубликована: Авг. 24, 2023
COVID-19
emerged
in
September
2020
as
a
disease
caused
by
the
virus
SARS-CoV-2.
The
presented
pneumonia
at
first
but
later
was
shown
to
cause
multisystem
infections
and
long-term
complications.
Many
efforts
have
been
put
into
discovering
exact
pathogenesis
of
disease.
In
this
review,
we
aim
discuss
an
emerging
tool
modeling,
organoids,
investigation
COVID-19.
This
review
will
introduce
some
methods
breakthroughs
achieved
organoids
limitations
system.
Pathogens,
Год журнала:
2024,
Номер
13(4), С. 316 - 316
Опубликована: Апрель 12, 2024
Respiratory
viral
coinfections
are
a
global
public
health
threat
that
poses
an
economic
burden
on
individuals,
families,
and
healthcare
infrastructure.
Viruses
may
coinfect
interact
synergistically
or
antagonistically,
their
coinfection
not
affect
replication
rate.
These
interactions
specific
to
different
virus
combinations,
which
underlines
the
importance
of
understanding
mechanisms
behind
these
differential
need
for
novel
diagnostic
methods
accurately
identify
multiple
viruses
causing
disease
in
patient
avoid
misdiagnosis.
This
review
examines
epidemiological
patterns,
pathology
manifestations,
immune
response
modulation
respiratory
combinations
occur
during
using
experimental
models
better
understand
dynamics
takes
driving
outcomes
severity,
is
crucial
guide
development
prevention
treatment
strategies.
FEMS Microbiology Reviews,
Год журнала:
2024,
Номер
48(2)
Опубликована: Фев. 26, 2024
Abstract
Bacterial
pneumonia
greatly
contributes
to
the
disease
burden
and
mortality
of
lower
respiratory
tract
infections
among
all
age
groups
risk
profiles.
Therefore,
laboratory
modelling
bacterial
remains
important
for
elucidating
complex
host–pathogen
interactions
determine
drug
efficacy
toxicity.
In
vitro
cell
culture
enables
creation
high-throughput,
specific
models
in
a
tightly
controlled
environment.
Advanced
human
specifically,
can
bridge
research
gap
between
classical
two-dimensional
animal
models.
This
review
provides
an
overview
current
status
development
cellular
study
infections,
with
focus
on
air–liquid
interface
models,
spheroid,
organoid,
lung-on-a-chip
For
wide
scale,
comparative
literature
search,
we
selected
six
clinically
highly
relevant
bacteria
(Pseudomonas
aeruginosa,
Mycoplasma
pneumoniae,
Haemophilus
influenzae,
Mycobacterium
tuberculosis,
Streptococcus
Staphylococcus
aureus).
We
reviewed
lines
that
are
commonly
used,
as
well
trends
discrepancies
methodology,
ranging
from
infection
parameters
assay
read-outs.
also
highlighted
importance
model
validation
data
transparency
guiding
field
towards
more
Cells,
Год журнала:
2023,
Номер
12(14), С. 1854 - 1854
Опубликована: Июль 14, 2023
One
major
challenge
associated
with
lung
cancer
organoids
(LCOs)
is
their
predominant
derivation
from
surgical
specimens
of
patients
early-stage
cancer.
However,
advanced
cancer,
who
are
in
need
chemotherapy,
often
cannot
undergo
surgery.
Therefore,
there
an
urgent
to
successfully
generate
LCOs
biopsy
specimens.
Conventional
techniques,
such
as
transthoracic
needle
and
forceps
biopsy,
only
yield
small
amounts
tissue,
resulting
a
low
success
rate
for
culturing
samples.
Furthermore,
potential
complications,
like
bleeding
pneumothorax,
make
it
difficult
obtain
sufficient
tissue.
Another
critical
issue
the
overgrowth
normal
cells
later
passages
LCO
culture,
optimal
culture
conditions
yet
be
determined.
To
address
these
limitations,
we
attempted
create
cryobiopsy
obtained
(n
=
113).
Overall,
initial
establishing
samples
was
40.7%
46).
Transbronchial
enables
retrieval
significantly
larger
tissue
than
bronchoscopic
biopsy.
Additionally,
can
employed
peripheral
lesions,
aided
via
radial
endobronchial
ultrasonography.
This
study
improved
demonstrated
that
retained
characteristics
resembled
primary
tumors.
Single-cell
RNA
sequencing
confirmed
high
cell
purity
early
derived
three-dimensional
structure
intracellular
components
were
characterized
using
holotomography.
Finally,
drug
screening
performed
specialized
micropillar
system
cryobiopsy-derived
LCOs.
offer
promising
solution
limitations
conventional
Cryobiopsy
applied
at
all
stages,
including
those
provide
generation.
anticipate
will
serve
breakthrough
strategy
clinical
application
stages
Stem Cell Research & Therapy,
Год журнала:
2024,
Номер
15(1)
Опубликована: Май 31, 2024
Abstract
Mitochondrial
transplantation
and
transfer
are
being
explored
as
therapeutic
options
in
acute
chronic
diseases
to
restore
cellular
function
injured
tissues.
To
limit
potential
immune
responses
rejection
of
donor
mitochondria,
current
clinical
applications
have
focused
on
delivery
autologous
mitochondria.
We
recently
convened
a
Transplant
Convergent
Working
Group
(CWG),
explore
three
key
issues
that
translation:
(1)
storage
(2)
biomaterials
enhance
mitochondrial
uptake,
(3)
dynamic
models
mimic
the
complex
recipient
tissue
environment.
In
this
review,
we
present
summary
CWG
conclusions
related
these
provide
an
overview
pre-clinical
studies
aimed
at
building
more
robust
toolkit
for
translational
trials.
Frontiers in Cellular and Infection Microbiology,
Год журнала:
2024,
Номер
13
Опубликована: Янв. 8, 2024
Sepsis
is
a
global
health
concern
accounting
for
more
than
1
in
5
deaths
worldwide.
now
defined
as
life-threatening
organ
dysfunction
caused
by
dysregulated
host
response
to
infection.
can
develop
from
bacterial
(gram
negative
or
gram
positive),
fungal
viral
(such
COVID)
infections.
However,
therapeutics
developed
animal
models
and
traditional
vitro
sepsis
have
had
little
success
clinical
trials,
these
failed
fully
replicate
the
underlying
pathophysiology
heterogeneity
of
disease.
The
current
understanding
that
highly
diverse
among
patients,
this
impacts
immune
function
Phenotyping
classifying
patients
into
specific
endotypes
needed
personalized
treatment
approach.
Neutrophil-endothelium
interactions
play
critical
role
progression,
increased
neutrophil
influx
endothelial
barrier
disruption
important
roles
early
course
damage.
Understanding
mechanism
neutrophil-endothelium
how
interaction
help
us
better
manage
disease
lead
discovery
new
diagnostic
prognosis
tools
effective
treatments.
In
review,
we
will
discuss
latest
research
exploring
silico
modeling
synergistic
combination
organ-on-chip
incorporating
human
cells/tissue,
omics
analysis
data
allow
identify
relevant
signaling
pathways
characterize
phenotypes
patients.
Emerging
technologies
such
machine
learning
then
be
leveraged
druggable
therapeutic
targets
relate
them
infectious
agents.
This
approach
development
identification
FDA
approved
drugs
repurposed
sepsis.
Bioprinting,
Год журнала:
2024,
Номер
40, С. e00342 - e00342
Опубликована: Апрель 21, 2024
Respiratory
tissue
engineering
offers
a
robust
framework
for
studying
cell-cell
and
host-pathogen
interactions
in
tissue-like
environment
platform
lung
regeneration
disease
mechanisms.
However,
the
challenge
of
replicating
dynamic
three-dimensional
(3D)
microenvironments
is
huge
obstacle
with
existing
technology.
Current
animal
models
two-dimensional
cell
culture
do
not
replicate
vivo
conditions
seen
human
lungs,
thus
research
utilizing
these
techniques
often
fails
to
help
alleviate
global
burden
respiratory
diseases.
has
been
drawing
significant
attention
over
past
decade.
Particularly
emergence
severe
acute
syndrome
coronavirus
2
(SARS-CoV-2),
many
inspiring
developments
advances
have
reported.
This
review
presents
recent
focusing
on
3D
bioprinting,
organ-on-a-chip,
organoid
technologies.
It
also
provides
an
overview
attempts
integrate
biomechanical
stimulus
aim
improving
integrity
constructs
enhancing
cellular
propagation.
addresses
challenges
inherent
discusses
future
prospects
this
field,
urging
continuing
innovation
investment
toward
success
increasing
clinical
relevance.
European Journal of Pharmaceutical Sciences,
Год журнала:
2023,
Номер
191, С. 106596 - 106596
Опубликована: Сен. 26, 2023
Chronic
respiratory
diseases
and
infections
are
among
the
largest
contributors
to
death
globally,
many
of
which
still
have
no
cure,
including
chronic
obstructive
pulmonary
disorder,
idiopathic
fibrosis,
syncytial
virus
others.
Pulmonary
therapeutics
afford
untapped
potential
for
treating
lung
infection
disease
through
direct
delivery
site
action.
However,
ability
innovate
new
therapeutic
paradigms
will
rely
on
modeling
human
microenvironment
key
cellular
interactions
that
drive
disease.
One
feature
is
air-liquid
interface
(ALI).
ALI
techniques,
using
cell-culture
inserts,
organoids,
microfluidics,
precision
slices
(PCLS),
rapidly
developing;
however,
one
major
component
these
models
lacking—innate
immune
cell
populations.
Macrophages,
neutrophils,
dendritic
cells,
others,
represent
populations,
acting
as
first
responders
during
or
injury.
Innate
cells
respond
modulate
stromal
bridge
gap
between
innate
adaptive
system,
controlling
bodies
response
foreign
pathogens
debris.
In
this
article,
we
review
current
state
culture
systems
with
a
focus
suggest
ways
build
add
complexity
relevant
International Archives of Allergy and Immunology,
Год журнала:
2024,
Номер
unknown, С. 1 - 15
Опубликована: Июнь 17, 2024
<b><i>Background:</i></b>
Eosinophils
have
numerous
roles
in
type
2
inflammation
depending
on
their
activation
states
the
blood
and
airway
or
after
encounter
with
inflammatory
mediators.
Airway
epithelial
cells
a
sentinel
role
lung
and,
by
instructing
eosinophils,
likely
foundational
asthma
pathogenesis.
<b><i>Summary:</i></b>
In
this
review,
we
discuss
various
topics
related
to
eosinophil-epithelial
cell
interactions
asthma,
including
influence
of
eosinophils
eosinophil
products,
e.g.,
granule
proteins,
function,
expression,
secretion,
plasticity;
effects
released
factors,
oxylipins,
cytokines,
other
mediators
activation,
survival;
possible
mechanisms
adhesion;
intra-epithelial
asthma.
<b><i>Key
Messages:</i></b>
We
suggest
that
products
can
both
injurious
beneficial
there
are
bidirectional
signaling
between
Clinical
outcome
after
traumatic
brain
injury
(TBI)
is
closely
associated
conditions
of
other
organs,
especially
lungs
as
well
degree
injury.
Even
if
there
no
direct
lung
damage,
severe
can
enhance
sympathetic
tones
on
blood
vessels
and
vascular
resistance,
resulting
in
neurogenic
pulmonary
edema.
Conversely,
damage
worsen
by
dysregulating
immunity.
These
findings
suggest
the
importance
brain-lung
axis
interactions
TBI.
However,
little
research
has
been
conducted
topic.
An
advanced
disease
model
using
stem
cell
technology
may
be
an
alternative
for
investigating
simultaneously
but
separately,
they
potential
candidates
improving
clinical
outcomes
TBI.In
this
review,
we
describe
TBI
focusing
concepts
reproducibility
organoids
vitro.
We
also
summarize
recent
pluripotent
cell-derived
their
preclinical
applications
various
explore
how
mimic
axis.
Reviewing
current
status
discussing
limitations
perspectives
organoid
offer
a
better
understanding
pathophysiological
between